載入...
The off-label use of targeted therapies in sarcomas: the OUTC’S program
BACKGROUND: Few targeted therapies (TTs) are registered for sarcoma treatment despite numerous phase II studies and yet there are potential treatment options for patients after standard treatment escape. The French Sarcoma Group - Bone Tumor Study Group (GSF-GETO) created a national registry to eval...
Na minha lista:
| 發表在: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4289372/ https://ncbi.nlm.nih.gov/pubmed/25420707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-870 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|